Non-invasive and radiation-free assessment for early rule-out of significant CAD.
An AI-powered acoustic diagnostic aid to rule out significant coronary artery disease in 10 minutes.*
Use CADScor®System to Determine if Chest Pain is Related to the Heart*
CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced AI to analyze the patient's coronary blood flow.¹ In just 10 minutes, it calculates a patient-specific CAD-score, indicating the patient’s risk of significant coronary stenosis. CADScor®System has been used in over 24,000 patient assessments³ and has CE-marking and FDA De Novo clearance.
CADScor®System Uses Ultra-Sensitive Acoustics and AI to Rapidly Rule-Out Significant Coronary Artery Disease in 10 Minutes¹*
Can help save costs of more advanced CAD diagnostics in up to 35% of patients.²
Rapid and easy-to-use, with clear results in 10 minutes.
An Individual CAD-score Indicates Low or Elevated Significant CAD Risk in Patients
The CAD-score is based on a phonocardiographic assessment, AI-powered calculations and risk factors.¹
Significant CAD rule-out in 35% of patients². Seek alternative diagnosis for symptoms.
Significant CAD cannot be ruled out. Refer for further diagnostics.
CADScor®System Research, Development and Clinical Studies
CADScor®System is approved in Europe with CE-marking and has received FDA De Novo clearance as a diagnostic aid for symptomatic patients with suspected CAD. Multiple clinical studies have been published to demonstrate CADScor®System’s performance.
Physicians’ Experiences Using CADScor®SystemExplore customer feedback
Schedule a demo of the CADScor®System
Schedule a free demo of CADScor®System and learn how you can rule out significant CAD patients in 10 minutes.*
- Winther S, et al. Heart 2018;104:928–935 (Dan-NICAD I)
- User manual US-FDA v.12.Y, prevalence 10,7%
- Based on commercial patch use since 2017